Regulatory roles of rs2192932 and rs10487150 in autism spectrum disorder: insights from fine-mapping and cross-population validation
Human Molecular Genetics · 2025
DOI: 10.1093/hmg/ddaf107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Shuai Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal and Child Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong Universi…. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Huazhong University of Science and Technology, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder with increasing global prevalence. GWAS have identified many ASD risk loci, but most are in non-coding regions, and the genetic value of nearby loci remains underexplored. We aim to conduct a fine-mapping analysis of ASD-associated SNPs and validate the signals across ethnic groups, focusing on their regulatory effects on gene expression. Variants within ±500 kb of known ASD loci were selected. Functional annotations were performed using RegulomeDB and CADD. ASD susceptibility genes were obtained from AutDB and SFARI, and screened for validation using 11 high-quality GEO datasets. eQTL analysis was conducted using GTEx database. For Chinese children, a case–control study design was adopted. Biological samples and demographic information were collected from 1244 children between 2010–2024. Extracted DNA was used for ASAMD chip. For European children, GWAS data from 46351 samples were obtained from iPSYCH-PGC-ASD project. 158 ASD susceptibility SNPs with cis-eQTL signals in brain tissue were identified. Notably, rs2192932 and rs10487150 showed consistent associations with ASD in both populations. In additive model, a G to A change at rs2192932 increased ASD risk by 29.5% (OR = 1.295, 95% CI: 1.046–1.605, P = 0.018), while an A to C change at rs10487150 increased risk by 22.7% (OR = 1.227, 95% CI: 1.008–1.495, P = 0.042). Additionally, rs2192932 and rs10487150 may influence ASD onset by regulating SERPINE1 expression. These findings offer new insights into the molecular genetics of ASD and support the potential of genetic markers for risk prediction and early screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Maternal and Child Health and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, No 13 Hangkong Road, Wuhan, Hubei, 43003…
- Department of Child Healthcare, Maternity and Children Health Care Hospital of Luohu District, No 2013 Taibai Road, Shenzhen, Guangdong, 518019, China.
Förderung
- Huazhong University of Science and Technology
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Zhao, S., Wang, H., Hou, F., Chen, Y., Zhu, K., Liu, R., Xiang, Z., Zhang, J., Liang, X., Li, L., & Song, R. (2025). Regulatory roles of rs2192932 and rs10487150 in autism spectrum disorder: insights from fine-mapping and cross-population validation. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf107
Vancouver
Zhao S, Wang H, Hou F, Chen Y, Zhu K, Liu R, et al. Regulatory roles of rs2192932 and rs10487150 in autism spectrum disorder: insights from fine-mapping and cross-population validation. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf107
BibTeX
@article{Zhao2025,
author = {Zhao, Shuai and Wang, Haoxue and Hou, Fang and Chen, Yanlin and Zhu, Kaiheng and Liu, Rundong and Xiang, Zhen and Zhang, Jiao and Liang, Xi and Li, Li and Song, Ranran},
title = {Regulatory roles of rs2192932 and rs10487150 in autism spectrum disorder: insights from fine-mapping and cross-population validation},
journal = {Human Molecular Genetics},
year = {2025},
doi = {10.1093/hmg/ddaf107}
}
EUVIMED